These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29588449)

  • 1. Confirmation of a metastasis-specific microRNA signature in primary colon cancer.
    Coebergh van den Braak RRJ; Sieuwerts AM; Lalmahomed ZS; Smid M; Wilting SM; Bril SI; Xiang S; van der Vlugt-Daane M; de Weerd V; van Galen A; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; ; Martens JWM; IJzermans JNM
    Sci Rep; 2018 Mar; 8(1):5242. PubMed ID: 29588449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer.
    Bobowicz M; Skrzypski M; Czapiewski P; Marczyk M; Maciejewska A; Jankowski M; Szulgo-Paczkowska A; Zegarski W; Pawłowski R; Polańska J; Biernat W; Jaśkiewicz J; Jassem J
    Clin Exp Metastasis; 2016 Dec; 33(8):765-773. PubMed ID: 27485175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
    Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
    FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer.
    Oue N; Anami K; Schetter AJ; Moehler M; Okayama H; Khan MA; Bowman ED; Mueller A; Schad A; Shimomura M; Hinoi T; Aoyagi K; Sasaki H; Okajima M; Ohdan H; Galle PR; Yasui W; Harris CC
    Int J Cancer; 2014 Apr; 134(8):1926-34. PubMed ID: 24122631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.
    Weissmann-Brenner A; Kushnir M; Lithwick Yanai G; Aharonov R; Gibori H; Purim O; Kundel Y; Morgenstern S; Halperin M; Niv Y; Brenner B
    Int J Oncol; 2012 Jun; 40(6):2097-103. PubMed ID: 22426940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
    Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
    EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA expression signature as a predictor of survival for colon adenocarcinoma.
    Xu M; Kuang Y; Wang M; Han X; Yang Q
    Neoplasma; 2017; 64(1):56-64. PubMed ID: 27881005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.
    Giráldez MD; Lozano JJ; Cuatrecasas M; Alonso-Espinaco V; Maurel J; Mármol M; Hörndler C; Ortego J; Alonso V; Escudero P; Ramírez G; Petry C; Lasalvia L; Bohmann K; Wirtz R; Mira A; Castells A
    Int J Cancer; 2013 Mar; 132(5):1090-7. PubMed ID: 22833293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer.
    Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
    Sci Rep; 2018 Apr; 8(1):6157. PubMed ID: 29670141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.
    Caritg O; Navarro A; Moreno I; Martínez-Rodenas F; Cordeiro A; Muñoz C; Ruiz-Martinez M; Santasusagna S; Castellano JJ; Monzó M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e175-e182. PubMed ID: 27247088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and validation of a 10-gene predictive signature for response to adjuvant chemotherapy in stage II and III colon cancer.
    Xu C; Xia P; Li J; Lewis KB; Ciombor KK; Wang L; Smith JJ; Beauchamp RD; Chen XS
    Cell Rep Med; 2024 Aug; 5(8):101661. PubMed ID: 39059386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
    Schetter AJ; Leung SY; Sohn JJ; Zanetti KA; Bowman ED; Yanaihara N; Yuen ST; Chan TL; Kwong DL; Au GK; Liu CG; Calin GA; Croce CM; Harris CC
    JAMA; 2008 Jan; 299(4):425-36. PubMed ID: 18230780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.
    Jiang Y; Casey G; Lavery IC; Zhang Y; Talantov D; Martin-McGreevy M; Skacel M; Manilich E; Mazumder A; Atkins D; Delaney CP; Wang Y
    J Mol Diagn; 2008 Jul; 10(4):346-54. PubMed ID: 18556775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma.
    Schetter AJ; Nguyen GH; Bowman ED; Mathé EA; Yuen ST; Hawkes JE; Croce CM; Leung SY; Harris CC
    Clin Cancer Res; 2009 Sep; 15(18):5878-87. PubMed ID: 19737943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer.
    Siemens H; Neumann J; Jackstadt R; Mansmann U; Horst D; Kirchner T; Hermeking H
    Clin Cancer Res; 2013 Feb; 19(3):710-20. PubMed ID: 23243217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.
    Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.